<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="to challenging decision-making about treatment of critically unwell patients. Low-dose" exact="prednisolone" post="and tacrolimus may have beneficial impacts on COVID-19. The"/>
 <result pre="decision-making about treatment of critically unwell patients. Low-dose prednisolone and" exact="tacrolimus" post="may have beneficial impacts on COVID-19. The mycophenolate mofetil"/>
 <result pre="There is no definitive evidence that specific cytotoxic drugs, low-dose" exact="methotrexate" post="for auto-immune disease, NSAIDs, JAK kinase inhibitors or anti-TNFα"/>
 <result pre="relation to specific treatments: Although HIV protease inhibitors such as" exact="lopinavir" post="has been suggested as a low-micromolar inhibitor of MERS-CoV,"/>
 <result pre="Currently, there is no scientific evidence of the interaction between" exact="methotrexate" post="and COVID-19. Low-dose steroids and NSAIDs Since the outbreak"/>
 <result pre="identify any strong evidence for or against the use of" exact="ibuprofen" post="for treatment of COVID-19 specifically. One study did however"/>
 <result pre="downregulation of angiotensin converting enzyme-2 (ACE2) which is upregulated by" exact="ibuprofen" post="[12]. The authors of this study were investigating the"/>
 <result pre="investigate a non-steroidal anti-inflammatory drug was one which looked at" exact="indomethacin" post="[13]. This study suggested that indomethacin exhibited potent antiviral"/>
 <result pre="one which looked at indomethacin [13]. This study suggested that" exact="indomethacin" post="exhibited potent antiviral activity against canine coronavirus (dramatically inhibiting"/>
 <result pre="laboratory study which treated porcine respiratory coronavirus infected pigs with" exact="dexamethasone" post="suggested that one or two doses of the corticosteroid"/>
 <result pre="TNFa can be achieved with a monoclonal antibody, such as" exact="infliximab" post="(Remicade), adalimumab (Humira), certolizumab pegol (Cimzia) and golimumab (Simponi),"/>
 <result pre="be achieved with a monoclonal antibody, such as infliximab (Remicade)," exact="adalimumab" post="(Humira), certolizumab pegol (Cimzia) and golimumab (Simponi), or with"/>
 <result pre="with a monoclonal antibody, such as infliximab (Remicade), adalimumab (Humira)," exact="certolizumab pegol" post="(Cimzia) and golimumab (Simponi), or with the receptor fusion"/>
 <result pre="such as infliximab (Remicade), adalimumab (Humira), certolizumab pegol (Cimzia) and" exact="golimumab" post="(Simponi), or with the receptor fusion protein etanercept (Enbrel)."/>
 <result pre="(Cimzia) and golimumab (Simponi), or with the receptor fusion protein" exact="etanercept" post="(Enbrel). Results A total of three studies were identified,"/>
 <result pre="receptor antibody was developed. Other approved anti IL-6 drugs are" exact="siltuximab" post="(Sylvant) and sarilumab. Several agents are in clinical trials:olokizumab"/>
 <result pre="of human nasal and tracheal epithelial cells with glycopyrronium or" exact="formoterol" post="decreased viral RNA levels and/or titers, the expression of"/>
 <result pre="of the cells with a combination of three drugs (glycopyrronium," exact="formoterol" post="and budesonide) exerted additive inhibitory effects on viral titers"/>
 <result pre="further clinical data becomes available. In vitro treatment with glycopyrronium," exact="formoterol" post="and budesonide exerted additive inhibitory effects on viral titers"/>
 <result pre="data becomes available. In vitro treatment with glycopyrronium, formoterol and" exact="budesonide" post="exerted additive inhibitory effects on viral titers and cytokine"/>
 <result pre="Those patients with more severe disease were treated with pulsed" exact="methylprednisolone" post="and IL-1β levels returned to normal after 7 days."/>
 <result pre="human coronaviruses. Mycophenolate Mycophenolate mofetil (which is a derivative of" exact="mycophenolic acid" post="(MPA)) is an immune suppressant, antineoplastic and antiviral mediation."/>
 <result pre="the cohort who received a variety of antiviral agents including" exact="ribavirin" post="and IFN-a, steroids and antibiotics. Therefore, the results must"/>
 <result pre="Overall, the literature appeared to suggest a potential role for" exact="tacrolimus" post="in the treatment of human coronaviruses. In a case"/>
 <result pre="patient who was being treated with an immunosuppressive regimen of" exact="tacrolimus" post="underwent full recovery whilst the other patient (who was"/>
 <result pre="of SARS-CoV non-structural protein 1. Subsequently, the authors investigated whether" exact="tacrolimus" post="inhibits viral replication of human coronaviruses. VeroFM cells infected"/>
 <result pre="and disadvantages associated with using one of these medications. Low-dose" exact="prednisolone" post="and tacrolimus therapy may have beneficial impacts on the"/>
 <result pre="associated with using one of these medications. Low-dose prednisolone and" exact="tacrolimus" post="therapy may have beneficial impacts on the course of"/>
 <result pre="There is no definitive evidence that specific cytotoxic drugs, low-dose" exact="methotrexate" post="for auto-immune disease, NSAIDs, JAK kinase inhibitors or anti-TNFa"/>
 <result pre="it has high cytotoxicity. HIV protease inhibitor nelfinavir, antihelminthic drug" exact="niclosamide" post="and antimalarial agent chloroquine have also showed strong inhibitory"/>
 <result pre="HIV protease inhibitor nelfinavir, antihelminthic drug niclosamide and antimalarial agent" exact="chloroquine" post="have also showed strong inhibitory activity against SARS-CoV replication."/>
 <result pre="Lu China 2020 No evidence given for or against using" exact="ibuprofen" post="only that ‘anti-inflammatory drugs (such as hormones and other"/>
 <result pre="various viruses including Dengue, Ebola and SARS-CoV. They stated that" exact="ribavirin" post="(an antiviral) is the most frequently used drug to"/>
 <result pre="study which treated porcine respiratory coronavirus infected pigs with corticosteroid" exact="dexamethasone" post="as a model for SARS.Goal to define whether corticosteroid"/>
 <result pre="pig lung lesions.Confirmed infection model applicable and resembled SARS.Treatment with" exact="dexamethasone" post="suppressed early local IL-6 levels but increased later on"/>
 <result pre="at early infection stage but not later.Results also suggest that" exact="dexamethasone" post="induced reduction of IL-6 might play a role in"/>
 <result pre="with corticosteroids).Overall findings suggest that 1 or 2 doses of" exact="dexamethasone" post="in acute phase of infection may effectively alleviate early"/>
 <result pre="against several RNA viruses to investigate effect of COX inhibitor" exact="indomethacin" post="on coronavirus replication.Indomethacin is common NSAID.Report describes how indomethacin"/>
 <result pre="inhibitor indomethacin on coronavirus replication.Indomethacin is common NSAID.Report describes how" exact="indomethacin" post="was unexpectedly found to possess potent antiviral activity against"/>
 <result pre="cytokines.Numerous papers published outcomes of patients administered corticosteroids (mostly IV" exact="hydrocortisone" post="or methylprednisolone) in either early low-dose or pulsed-dose strategies."/>
 <result pre="hypokalaemia, hypertension, gastrointestinal haemorrhage and avascular necrosis (AVN). [33] High-dose" exact="hydrocortisone" post="reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10"/>
 <result pre="CXCL8 and CXCL10 in human intestinal epithelial cells.High concentrations of" exact="hydrocortisone" post="prevented DNA binding activity of AP-1 and NF-kappabeta and"/>
 <result pre="use of high-dose steroids in combination with a quinolone plus" exact="azithromycin" post="gave the best outcome with improvement of clinical signs"/>
 <result pre="H5N1 influenza and SARS coronavirus. In humans, anti-TNF therapy utilising" exact="etanercept" post="has been reported to be beneficial for treatment of"/>
 <result pre="of virus-endotoxin-induced respiratory disease.The study demonstrates that after intratracheal administration" exact="etanercept" post="is able to successfully block TNF-α activity in vivo"/>
 <result pre="including viral infections. [40] Inhibitory effects of glycopyrronium, formoterol, and" exact="budesonide" post="on coronavirus HCoV-229E replication and cytokine production by primary"/>
 <result pre="coronavirus. Pretreatment of HNE and HTE cells with glycopyrronium or" exact="formoterol" post="decreased viral RNA levels and/or titers, the expression of"/>
 <result pre="link between viral load, ribavirin, proinflammatory cytokines, and clinical progression." exact="ribavirin" post="was not effective in reducing the SARS coronavirus load"/>
 <result pre="Country of study Year Summary of results [68] Interferon-β and" exact="mycophenolic acid" post="are potent inhibitors of middle east respiratory syndrome coronavirus"/>
 <result pre="of 2.87 mM. This drug may provide an alternative to" exact="ribavirin" post="for treatment of MERS-CoV. In conclusion, IFN-b, MPA or"/>
 <result pre="drugsMultiple inhibition assays also support a kinetic mechanism by which" exact="disulfiram" post="together with 6TG and/or MPA can synergistically inhibit MERS-CoV"/>
 <result pre="mode of inhibition, SARS-CoV PLpro.Synergistic inhibition of MERS-CoV PLpro by" exact="disulfiram" post="and 6-thioguanine or mycophenolic acid implies the potential for"/>
 <result pre="PLpro.Synergistic inhibition of MERS-CoV PLpro by disulfiram and 6-thioguanine or" exact="mycophenolic acid" post="implies the potential for combination treatments using these three"/>
 <result pre="using these three clinically available drugs. [70] Thiopurine analogs and" exact="mycophenolic acid" post="synergistically inhibit the papain-like protease of Middle East respiratory"/>
 <result pre="target MERS-CoV PLpro. The authors report that the immunosuppressive drug" exact="mycophenolic acid," post="was able to inhibit MERS-CoV PLpro.MPA is a non-competitive"/>
 <result pre="vitro)The authors assessed the anti-MERS-CoV activities of several compounds. Only" exact="mycophenolic acid" post="exhibited low EC50 and high selectivity index.They found that"/>
 <result pre="EC50 and high selectivity index.They found that a combination of" exact="mycophenolic acid" post="and IFN-b1b lowered the EC50 of each drug by"/>
 <result pre="the salt mycophenolate sodium, and could be given orally.Interferon-b1b with" exact="mycophenolic acid" post="should be considered in treatment trials of MERS. [72]"/>
 <result pre="They concluded that they had identified seven compounds (lycorine, emetine," exact="monensin" post="sodium, mycophenolate mofetil, mycophenolic acid, phenazopyridine, and pyrvinium pamoate)"/>
 <result pre="had identified seven compounds (lycorine, emetine, monensin sodium, mycophenolate mofetil," exact="mycophenolic acid," post="phenazopyridine, and pyrvinium pamoate) as broad-spectrum inhibitors according to"/>
 <result pre="of all CoVs with EC50 values of 5μm.Mycophenolate mofetil and" exact="mycophenolic acid," post="showed a similar antiviral effect on the four CoVs"/>
 <result pre="only)The authors assessed the antiviral activities of ribavirin, 6-azauridine, pyrazofurin," exact="mycophenolic acid," post="and glycyrrhizin against two clinical isolates of coronavirus (FFM-1"/>
 <result pre="of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including" exact="ribavirin" post="Barnard et al USA 2006 In vivo study in"/>
 <result pre="and autoimmune diseases such as systemic lupus erythematosus.The use of" exact="mycophenolic acid" post="monotherapy has not been reported in MERS. IFN-b and"/>
 <result pre="acid monotherapy has not been reported in MERS. IFN-b and" exact="mycophenolic acid" post="combination therapy was described in a retrospective observational study"/>
 <result pre="patients; all of the 8 patients who received IFN-b and" exact="mycophenolic acid" post="survived.Corticosteroids, ribavirin monotherapy and mycophenolic acid are likely to"/>
 <result pre="the 8 patients who received IFN-b and mycophenolic acid survived.Corticosteroids," exact="ribavirin" post="monotherapy and mycophenolic acid are likely to cause more"/>
 <result pre="who received IFN-b and mycophenolic acid survived.Corticosteroids, ribavirin monotherapy and" exact="mycophenolic acid" post="are likely to cause more harm than benefit.There are"/>
 <result pre="than benefit.There are no clinical data on the efficacy of" exact="mycophenolic acid" post="in SARS or MERS. However, it led to severe"/>
 <result pre="disease Chan et al Hong Kong/China 2015 (Review)The combination of" exact="mycophenolic acid" post="and interferon beta 1b shows synergistic activity against MERS-CoV"/>
 <result pre="activity against MERS-CoV in Vero cells. The desirable pharmacokinetics of" exact="mycophenolic acid" post="compared to ribavirin warrants further evaluation, although the potential"/>
 <result pre="Vero cells. The desirable pharmacokinetics of mycophenolic acid compared to" exact="ribavirin" post="warrants further evaluation, although the potential inhibitory effect on"/>
 <result pre="infectious bronchitis virusVirology2011420210611610.1016/j.virol.2011.09.00321959016 42.YamayaMNishimuraHDengXet al.Inhibitory effects of glycopyrronium, formoterol, and" exact="budesonide" post="on coronavirus HCoV-229E replication and cytokine production by primary"/>
 <result pre="papain-like proteases via different modesAntiviral Res201815015516310.1016/j.antiviral.2017.12.01529289665 54.ChengKWChengSCChenWYet al.Thiopurine analogs and" exact="mycophenolic acid" post="synergistically inhibit the papain-like protease of Middle East respiratory"/>
 <result pre="of potent broad-spectrum inhibitors of coronavirusesJ Virol2019931210.1128/JVI.00023-19 57.HartBJDyallJPostnikovaEet al.Interferon-beta and" exact="mycophenolic acid" post="are potent inhibitors of Middle East respiratory syndrome coronavirus"/>
 <result pre="coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive" exact="cyclosporine" post="A-derivatives including AlisporivirVirus Res2014184445310.1016/j.virusres.2014.02.01024566223 References References 1.ZhuWJWangJHeXHet al.[The differential"/>
 <result pre="for severe acute respiratory syndromeExpert Rev Anti-infect Ther20053225126210.1586/14787210.3.2.25115918782 33.CinatlJMichaelisMMorgensternBet al.High-dose" exact="hydrocortisone" post="reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10"/>
 <result pre="Regul Homeost Agents2020342pii:1 40.YamayaMNishimuraHDengXet al.Inhibitory effects of glycopyrronium, formoterol, and" exact="budesonide" post="on coronavirus HCoV-229E replication and cytokine production by primary"/>
 <result pre="Agents2020341 67.ZhuMSARS immunity and vaccinationCell Mol Immunol20041319319816219167 68.HartBJDyallJPostnikovaEet al.Interferon-beta and" exact="mycophenolic acid" post="are potent inhibitors of Middle East respiratory syndrome coronavirus"/>
 <result pre="papain-like proteases via different modesAntiviral Res201815015516310.1016/j.antiviral.2017.12.01529289665 70.ChengKWChengSCChenWYet al.Thiopurine analogs and" exact="mycophenolic acid" post="synergistically inhibit the papain-like protease of Middle East respiratory"/>
 <result pre="coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive" exact="cyclosporine" post="A-derivatives including AlisporivirVirus Res184445324566223 Table 1. Search terms and"/>
 <result pre="COVID or betacoronavirus or MERS-CoV or SARS-CoV) AND (anti-inflammatory or" exact="ibuprofen" post="or isobutylphenylpropionic acid or cortisone or non-steroidal anti-inflammatory) 13/58"/>
 <result pre="AND (TNF blocker or Anti-TNF therapy or TNFα inhibitor or" exact="infliximab" post="or etanercept or Certolizumab or Golimumab or adalimumab)) 2/3"/>
 <result pre="blocker or Anti-TNF therapy or TNFα inhibitor or infliximab or" exact="etanercept" post="or Certolizumab or Golimumab or adalimumab)) 2/3 IL-6 blockade"/>
 <result pre="interlukin-6 blockage or IL 6 blockage or IL-6 blockage or" exact="tocilizumab" post="or siltuximab or Sylvant or sarilumab or olokizumab or"/>
 <result pre="or IL 6 blockage or IL-6 blockage or tocilizumab or" exact="siltuximab" post="or Sylvant or sarilumab or olokizumab or CDP6038 or"/>
 <result pre="or interlukin 6 or Anti-IL-6 therapy or IL-6 blockage or" exact="tocilizumab" post="or siltuximab)) 023/108 JAK inhibitors ((SARS-CoV-2 or coronavirus or"/>
 <result pre="SARS-CoV) and (JAK or JAK1 or JAK2 or TYK3 or" exact="tofacitinib" post="or baricitinib or filgotinib or peficitinib or ABT494 or"/>
 <result pre="MERS-CoV or SARS-CoV) AND (Interleukin-1 or IL-1 or IL-1RA or" exact="canakinumab" post="or anti-IL-1 or IL-1 antagonists or IL-1 blockers or"/>
 <result pre="canakinumab or anti-IL-1 or IL-1 antagonists or IL-1 blockers or" exact="rilonacept" post="or IL-1 trap or ACZ885 or anakinra) 9/37 Mycophenylate"/>
 <result pre="betacoronavirus or MERS-CoV or SARS-CoV) AND (envarsus or tacni or" exact="tacrolimus" post="or prograf or FK506) 3/18 Anti-CD20 ((SARS-CoV-2 or coronavirus"/>
 <result pre="MERS-CoV or SARS-CoV) AND (anti-cd20 monoclonal antibodies or anti-cd20 or" exact="rituximab" post="or truxima or zevalin or ruxience or rituxan or"/>
</results>
